Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,227
Closed -$302K 212
2025
Q4
$302K Buy
9,227
+172
+2% +$4.23K 0.02% 1202
2025
Q3
$162K Buy
9,055
+2,779
+44% +$40.3K 0.01% 1506
2025
Q2
$68.1K Buy
6,276
+5,637
+882% +$73.9K 0.01% 1549
2025
Q1
$11.8K Sell
639
-192
-23% -$3.46K ﹤0.01% 1781
2024
Q4
$13.7K Sell
831
-1,254
-60% -$17.8K ﹤0.01% 1450
2024
Q3
$29.2K Buy
2,085
+2,076
+23,067% +$23K ﹤0.01% 1481
2024
Q2
$65 Hold
9
﹤0.01% 1486
2024
Q1
$73 Hold
9
﹤0.01% 1603
2023
Q4
$61 Buy
+9
New +$50 ﹤0.01% 1048

Other funds holding AXGN

AlphaQuest's AXGN Position: Q1 2026 in Review

AlphaQuest sold out of Axogen (AXGN) in Q1 2026, closing a stake of 9,227 shares — an estimated $302K sold.

AlphaQuest first reported a position in AXGN in Q4 2023 and held it in 9 quarters. The position peaked at $302K in Q4 2025. 222 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • AlphaQuest reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 9,227 Axogen shares in Q1 2026, an estimated $302K.
  • AlphaQuest first reported a position in Axogen in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Axogen position peaked at $302K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.